Dataset Information


Vitamin K3 derivative induces apoptotic cell death in neuroblastoma via downregulation of MYCN expression.

ABSTRACT: Neuroblastoma is a pediatric malignant tumor arising from the sympathetic nervous system. The patients with high-risk neuroblastomas frequently exhibit amplification and high expression of the MYCN gene, resulting in worse clinical outcomes. Vitamin K3 (VK3) is a synthetic VK-like compound that has been known to have antitumor activity against various types of cancers. In the present study, we have asked whether VK3 and its derivative, VK3-OH, could have the antitumor activity against neuroblastoma-derived cells. Based on our results, VK3-OH strongly inhibited cell proliferation and induced apoptotic cell death compared to VK3. Treatment of MYCN-driven neuroblastoma cells with VK3-OH potentiated tumor suppressor p53 accompanied by downregulation of anti-apoptotic Bcl-2 and Mcl-1. Interestingly, VK3-OH also suppressed the MYCN at mRNA and protein levels. Furthermore, we found downregulation of LIN28B following VK3-OH treatment in MYCN-amplified and overexpressed neuroblastoma cells. Collectively, our current findings strongly suggest that VK3-OH provides a potential therapeutic strategy for patients with MYCN-driven neuroblastomas.


PROVIDER: S-EPMC6895568 | BioStudies | 2019-01-01

REPOSITORIES: biostudies

Similar Datasets

1000-01-01 | S-EPMC4749542 | BioStudies
2012-01-01 | S-EPMC3417812 | BioStudies
2020-01-01 | S-EPMC7527568 | BioStudies
1000-01-01 | S-EPMC4520635 | BioStudies
2008-01-01 | S-EPMC2760877 | BioStudies
2018-01-01 | S-EPMC5822637 | BioStudies
2018-01-01 | S-EPMC6386470 | BioStudies
1000-01-01 | S-EPMC5749506 | BioStudies
2015-01-01 | S-EPMC4523463 | BioStudies
2018-01-01 | S-EPMC5814222 | BioStudies